CompaniesAristea Therapeutics

Aristea Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

6

As Collaborator

0

Total Enrollment

177

By Phase

PHASE2: 4PHASE1: 2

By Status

COMPLETED: 3TERMINATED: 2WITHDRAWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT05448391
Hover over trial bars to see details

Recent Trials

NCT05448391Lead Sponsor
A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
PHASE2Withdrawn
Started: Sep 13, 2022 · Completed: Dec 30, 2024
NCT05348681Lead Sponsor
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
PHASE2Terminated
25 participants
Started: Jul 18, 2022 · Completed: Feb 28, 2023
NCT05194839Lead Sponsor
A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
PHASE2Terminated
79 participants
Started: Jan 5, 2022 · Completed: Mar 6, 2023
NCT05023811Lead Sponsor
A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects
PHASE1Completed
6 participants
Started: Aug 11, 2021 · Completed: Sep 15, 2021
NCT04105959Lead Sponsor
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
PHASE1Completed
32 participants
Started: Jul 25, 2019 · Completed: Dec 9, 2019
View all 6 trials →
Funding History (2)
D/A
Aug 5, 2021
Filing
D
Oct 20, 2020
Filing